Case Finland is a land of unwritten savings

Biologic medical treatment has revolutionized the treatment of many diseases but at the same time increased the society’s medicine reimbursement costs. Biosimilar is as safe, effective and reliable as the original biologic medicine, but it causes prize war that usually significantly lowers the costs of the entire medicine group.

The more doctors start or switch their patient’s treatment to biosimilar, the more savings will be achieved in medical costs. In other words, biosimilars enable biologic medical treatment to more patients. Compared to other Nordic Countries, Finland is still behind in the use of biosimilars. gives information about the effect the biosimilars have on the medical costs. With the index tool you can see how biosimilars are used in the whole land and in different areas of Finland.

In addition to the web page, we designed our client a multi-channel marketing campaign including social media campaign and direct mails to our target group.